この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Shilpa P.に依頼
India
Expert in cancer biology, Genetics, Biochemistry and Immunology, proficiency in scientific writing and literature review
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Technical Writing,
Copywriting
Research
Fact Checking,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis
Product Development
Formulation
職務経験
Postdoctoral research fellow
NCI, National Institutes of Health (NIH), Bethesda, USA
7月 2016 - 3月 2019
DBT-RA- Postdoctoral research fellow
NIMHANS, Bangalore, India
1月 2016 - 5月 2016
学歴
PhD, Oncology and Cancer biology
Indian Institute of Science, Bangalore, India
6月 2009 - 12月 2015
MSc, Masters in microbiology
University of Pune, Pune, India
6月 2007 - 6月 2009
B. Sc. in Microbiology, Genetics and Immunology
H.P.T. Arts and R.Y.K. Science college, Nashik, India
6月 2004 - 6月 2007
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
(2019). 12-Lipoxygenase is a Critical Mediator of Type II Pneumocyte Senescence, Macrophage Polarization and Pulmonary Fibrosis after Irradiation . Radiation research.
(2017). Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage . International journal of radiation oncology, biology, physics.
(2016). Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis . Neuro-oncology.
(2015). Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion . Journal of neuro-oncology.
(2015). Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers . Nanomedicine : nanotechnology, biology, and medicine.
(2014). 2-(Phenylazo)pyridineplatinum(II) catecholates showing photocytotoxicity, nuclear uptake, and glutathione-triggered ligand release . Inorganic chemistry.
(2014). Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion . Journal of neuro-oncology.